Biotech | July 10, 2023
Biotech startups are crucial to India’s future economy, says Dr Jitendra Singh
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Several late-stage pipeline products have the potential to address some of these unmet needs
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
Subscribe To Our Newsletter & Stay Updated
